Hepatitis C Virus Genotype 1 to 6 Protease Inhibitor Escape Variants: In Vitro Selection, Fitness, and Resistance Patterns in the Context of the Infectious Viral Life Cycle

Hepatitis C virus (HCV) NS3 protease inhibitors (PIs) are important components of novel HCV therapy regimens. Studies of PI resistance initially focused on genotype 1. Therefore, knowledge about the determinants of PI resistance for the highly prevalent genotypes 2 to 6 remains limited. Using Huh7.5...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Serre, Stéphanie B. N., Jensen, Sanne B., Ghanem, Lubna, Humes, Daryl G., Ramirez, Santseharay, Li, Yi-Ping, Krarup, Henrik, Bukh, Jens, Gottwein, Judith M.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2016
Teme:
Antiviral Agents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879388/
https://ncbi.nlm.nih.gov/pubmed/27021330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02929-15
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki